BR0014063A - Formulações papa uso parenteral de fosfato de estramustina com propriedades farmacológicas melhoradas - Google Patents
Formulações papa uso parenteral de fosfato de estramustina com propriedades farmacológicas melhoradasInfo
- Publication number
- BR0014063A BR0014063A BR0014063-5A BR0014063A BR0014063A BR 0014063 A BR0014063 A BR 0014063A BR 0014063 A BR0014063 A BR 0014063A BR 0014063 A BR0014063 A BR 0014063A
- Authority
- BR
- Brazil
- Prior art keywords
- formulations
- estramustine phosphate
- pharmacological properties
- parenteral use
- improved pharmacological
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9921954.5A GB9921954D0 (en) | 1999-09-16 | 1999-09-16 | Formulations for parenteral use of estramustine phosphate with improved pharmacological properties |
PCT/EP2000/007679 WO2001019338A1 (en) | 1999-09-16 | 2000-08-03 | Formulations for parenteral use of estramustine phosphate with improved pharmacological properties |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0014063A true BR0014063A (pt) | 2004-06-29 |
Family
ID=10861066
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0014063-5A BR0014063A (pt) | 1999-09-16 | 2000-08-03 | Formulações papa uso parenteral de fosfato de estramustina com propriedades farmacológicas melhoradas |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1212040A1 (ja) |
JP (1) | JP2003509355A (ja) |
KR (1) | KR20020059405A (ja) |
CN (1) | CN1177583C (ja) |
AU (1) | AU777763B2 (ja) |
BR (1) | BR0014063A (ja) |
CA (1) | CA2385063A1 (ja) |
CZ (1) | CZ2002943A3 (ja) |
EA (1) | EA005308B1 (ja) |
GB (1) | GB9921954D0 (ja) |
HK (1) | HK1047227A1 (ja) |
HU (1) | HUP0202621A2 (ja) |
IL (1) | IL148409A0 (ja) |
MX (1) | MXPA02002859A (ja) |
NO (1) | NO20021306L (ja) |
NZ (1) | NZ517631A (ja) |
PL (1) | PL353954A1 (ja) |
SK (1) | SK3452002A3 (ja) |
WO (1) | WO2001019338A1 (ja) |
ZA (1) | ZA200201743B (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7658913B2 (en) | 2005-11-28 | 2010-02-09 | Verrow Pharmaceuticals, Inc. | Compositions useful for reducing nephrotoxicity and methods of use thereof |
WO2012037704A1 (en) | 2010-09-21 | 2012-03-29 | Telefonaktiebolaget L M Ericsson (Publ) | Air-interface timing synchronization sharing |
WO2019094819A2 (en) * | 2017-11-09 | 2019-05-16 | Abon Pharmaceuticals, Llc | Intravenous delivery systems for chemotherapy drugs |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59108800A (ja) * | 1982-12-13 | 1984-06-23 | Japan Atom Energy Res Inst | 誘導ミサイル作用および制癌剤の徐放性機能をもつ微粒子 |
KR0166088B1 (ko) * | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
US5602112A (en) * | 1992-06-19 | 1997-02-11 | Supergen, Inc. | Pharmaceutical formulation |
GB9419153D0 (en) * | 1994-09-22 | 1994-11-09 | Erba Carlo Spa | Estramustine formulations with improved pharmaceutical properties |
US20020039594A1 (en) * | 1997-05-13 | 2002-04-04 | Evan C. Unger | Solid porous matrices and methods of making and using the same |
-
1999
- 1999-09-16 GB GBGB9921954.5A patent/GB9921954D0/en not_active Ceased
-
2000
- 2000-08-03 AU AU68363/00A patent/AU777763B2/en not_active Ceased
- 2000-08-03 EP EP00956409A patent/EP1212040A1/en not_active Withdrawn
- 2000-08-03 BR BR0014063-5A patent/BR0014063A/pt not_active IP Right Cessation
- 2000-08-03 CN CNB008129525A patent/CN1177583C/zh not_active Expired - Fee Related
- 2000-08-03 CA CA002385063A patent/CA2385063A1/en not_active Abandoned
- 2000-08-03 CZ CZ2002943A patent/CZ2002943A3/cs unknown
- 2000-08-03 EA EA200200369A patent/EA005308B1/ru not_active IP Right Cessation
- 2000-08-03 SK SK345-2002A patent/SK3452002A3/sk unknown
- 2000-08-03 IL IL14840900A patent/IL148409A0/xx unknown
- 2000-08-03 JP JP2001522973A patent/JP2003509355A/ja not_active Withdrawn
- 2000-08-03 PL PL00353954A patent/PL353954A1/xx not_active Application Discontinuation
- 2000-08-03 NZ NZ517631A patent/NZ517631A/en unknown
- 2000-08-03 WO PCT/EP2000/007679 patent/WO2001019338A1/en not_active Application Discontinuation
- 2000-08-03 HU HU0202621A patent/HUP0202621A2/hu unknown
- 2000-08-03 MX MXPA02002859A patent/MXPA02002859A/es unknown
- 2000-08-03 KR KR1020027003498A patent/KR20020059405A/ko not_active Application Discontinuation
-
2002
- 2002-03-01 ZA ZA200201743A patent/ZA200201743B/en unknown
- 2002-03-15 NO NO20021306A patent/NO20021306L/no not_active Application Discontinuation
- 2002-11-26 HK HK02108529.1A patent/HK1047227A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
EA200200369A1 (ru) | 2002-08-29 |
KR20020059405A (ko) | 2002-07-12 |
CA2385063A1 (en) | 2001-03-22 |
CZ2002943A3 (cs) | 2002-08-14 |
JP2003509355A (ja) | 2003-03-11 |
ZA200201743B (en) | 2003-05-28 |
IL148409A0 (en) | 2002-09-12 |
MXPA02002859A (es) | 2003-07-21 |
WO2001019338A1 (en) | 2001-03-22 |
CN1374858A (zh) | 2002-10-16 |
HUP0202621A2 (hu) | 2002-12-28 |
EA005308B1 (ru) | 2004-12-30 |
PL353954A1 (en) | 2003-12-15 |
SK3452002A3 (en) | 2002-08-06 |
NO20021306L (no) | 2002-04-24 |
AU777763B2 (en) | 2004-10-28 |
CN1177583C (zh) | 2004-12-01 |
NZ517631A (en) | 2004-01-30 |
GB9921954D0 (en) | 1999-11-17 |
AU6836300A (en) | 2001-04-17 |
EP1212040A1 (en) | 2002-06-12 |
NO20021306D0 (no) | 2002-03-15 |
HK1047227A1 (zh) | 2003-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9911046A (pt) | Uso de antidepressivos tricìclicos para analgesia local | |
PL357944A1 (en) | Intradermal-penetration agents for topical local anesthetic administration | |
CY1105953T1 (el) | Συνθεσεις για απελευθερωση συνδυασμων φαρμακων | |
BR0014071A (pt) | Formulações para uso parenteral de fosfato de estramustina e aminoácidos | |
IL140930A0 (en) | Compounds and compositions for delivering active agents | |
CA2338358A1 (en) | Compounds and compositions for delivering active agents | |
IT1311923B1 (it) | Composti farmaceutici. | |
NZ501235A (en) | Topical compositions containing emulsion of a discontinuous phase which is an eutectic mixture of two pharmaceutical agents and a continuous phase | |
GB9401894D0 (en) | New compositions of matter | |
AP2004003120A0 (en) | Combined use of antitumor indolopyrrolocarbazole derivatives and other antitumor agent | |
MXPA01008611A (es) | Compuestos y composiciones para suministrar agentes activos. | |
AU2274201A (en) | Compounds and compositions for delivering active agents | |
DE60137960D1 (de) | Pharmazeutische zusammensetzungen mit corticosteroiden und antiinfektiva | |
BR0014062A (pt) | Formulações para uso parenteral de fosfato de estramustina e sulfoalquileter ciclodextrinas | |
DE60223542D1 (de) | Zusammensetzung mit fulvestrant | |
BR0014063A (pt) | Formulações papa uso parenteral de fosfato de estramustina com propriedades farmacológicas melhoradas | |
BR9709316A (pt) | Composição farmacêutica para administração tópica no tratamento da vaginite | |
NO20020631L (no) | Formuleringer for parenteral bruk av estramustinfosfat og albumin | |
BRPI0113372B8 (pt) | composição veterinária com veículo modificado e ceftiofur | |
BR0112035A (pt) | peptìdeos antimicrobianos de novispirin | |
IT1318485B1 (it) | Uso di derivati di acidi biliari coniugati con complessi di ionimetallici nella visualizzazione diagnostica di sistemi microvascolari | |
NZ501987A (en) | Single, high dosage intravenous administration of estramustine phosphate | |
ES2084724T3 (es) | 3'-desamino-4'-desoxi-4'-amino-8-fluoroantraciclinas y procedimientos de preparacion. | |
Ross et al. | Fates of translocated cougars, Felis concolor, in Alberta | |
BR9814090A (pt) | Composição de drogas rapidamente solúvel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A, 8A E 9A ANUIDADES |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2008 DE 30/06/2009. |